Zouache, Moussa A.
Bennion, Alex
Hageman, Jill L.
Pappas, Christian
Richards, Burt T.
Hageman, Gregory S.
Funding for this research was provided by:
Research to Prevent Blindness (Unrestricted Grant, Unrestricted Grant)
National Eye Institute (R24EY017404)
Article History
Received: 29 June 2020
Accepted: 19 November 2020
First Online: 3 December 2020
Change Date: 21 May 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-021-90883-3
Competing interests
: GSH is a shareholder, consultant and co-founder of Voyant Biotherapeutics, LLC. GSH, CP and BR are inventors on patents and patent applications owned by the University of Utah. The other authors declare no competing interests.